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This paper presents a robust method for the conjugation of 
viologens to peptides using an amide coupling strategy that 
is compatible with standard Fmoc solid-phase peptide 
synthesis.  Methodology is presented for monitoring the 
mg-scale process quantitatively by UV spectroscopy.  This 
chemistry enables the synthesis of a broad range of 
asymmetric viologens in high yield at room temperature 
and is compatible with a wide range of functional groups, 
including amine, guanidinyl, thiol, carboxylic acid, phenol, 
and indole. 
 
Viologens1 are 1,1’-disubstituted derivatives of 4,4’-
bipyridine.  The dicationic salt can be reduced readily by one 
electron to form a reducing, blue colored radical cation, and 
by two electrons to the neutral quinoid.2  The redox and 
electrochromic properties of viologens have led to broad 
application in diverse areas including herbicides,3 electron-
transfer studies,4 molecular electronics,5 photo- and 
electrochromic materials,6 and supramolecular assemblies.7   
Viologens are typically made by nucleophlic substitution of 
bipyridine on alkyl halides or by reductive 4,4-coupling of 
pyridinium salts.1  Reductive coupling is only appropriate for 
symmetrical viologens, whereas the SN2 approach is useful for 
both symmetrical and asymmetrical viologens and is most 
commonly used.1-7 The first SN2 reaction with bipyridine can 
be carried out conveniently at room temperature, but 
quaternization of one nitrogen greatly diminishes the 
nucleophilicity of the second.  Therefore, a high yield of 
viologen requires elevated temperatures (e.g., refluxing 
acetonitrile), a large excess of alkyl halide, and up to several 
days of reaction time.  In many instances amidic couplings 
would be desirable due to their selectivity, stability, high yield 
under mild conditions (i.e., room temp), orthogonal reactivity 
to many other functional groups, and compatibility with 
proteins.  There are scattered reports of amidic coupling of 
viologens, but yields are invariably lower than expected 
despite the use of well-established coupling reagents.8 We 
have reported the coupling of viologens to peptides on solid 
support for the purpose of making self-assembled receptors for 
peptides,9 but the synthetic method has yielded inconsistent 
results as a function of the sequence used (e.g. sterically 
hindered sequences and peptides longer than 20 residues), and 
it has been difficult to troubleshoot. Here we discuss this 
chemistry in detail, provide a synthetic protocol, and describe 
methods for carefully monitoring each step.  These methods 
have allowed us to identify and solve problems with this 
approach, ultimately enabling the coupling of viologens to a 
wide variety of peptides in essentially quantitative yield at 
room temperature. 
 
SCHEME 1.  Synthetic Route to Viologen-Peptide Conjugates 
 
There are five steps to the synthesis of peptide-viologen 
conjugates (Scheme 1):  1) Standard Fmoc-protocol solid 
phase synthesis of the desired peptide sequence.  Installation 
of a glutamic acid residue, protected as a cumyl ester (i.e., 
cumyl glutamate), at each desired site of viologen conjugation, 
and acetylation of the N-terminal amine.  2) Selective 
deprotection of the cumyl ester residue(s) in dilute acid, while 
still on-resin.  3) Activation of the resulting carboxylic acid(s) 
to the pentafluorophenyl ester.  4) Coupling of an aminoalkyl 
viologen to the activated Glu residue(s).  5) Cleavage of the 
conjugate from the solid support and purification by high-
pressure liquid chromatography (HPLC).  While steps 1 and 5 
are standard in the solid-phase peptide synthesis, steps 2-4 
require careful technique for successful execution and high 
yield.  In particular, the activation and coupling steps are very 
sensitive to environmental water, and the deprotection and 
activation steps cannot be monitored by HPLC because the 
strong acid condition necessary to cleave the peptide from the 
resin also removes the protecting or activating groups from the 
peptide.  Therefore, we describe methods for using UV 
spectroscopy to quantitatively monitor the deprotection, 
activation, and coupling steps in order to confirm the progress 
of each reaction and to use as reliable metric for 
troubleshooting potentially problematic sequences.   
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Fmoc-based solid-phase peptide synthesis was chosen due 
to its broad use and ease of compatibility with machine-
assisted protocols.  Standard conditions for Fmoc-based 
synthesis require a protecting group at the site of viologen 
conjugation that is stable to basic conditions (e.g., piperidine) 
and that can be removed without disturbing the acid-labile 
resin linkage.  Allyl esters have been used to orthogonally 
protect acidic residues in Fmoc-scheme solid-phase peptide 
synthesis using a soluble Pd0 catalyst for deprotection.10 This 
reaction is, however, difficult to monitor by UV spectroscopy, 
and any residual trace of the catalyst would reduce the 
viologen.  We chose to conjugate the viologen groups to the 
carboxylic acid sidechain of glutamic acid residues, for which 
a cumyl ester (OCml) protecting group can be removed 
orthogonally in dilute acid without disturbing the resin linkage 
and standard sidechain protecting groups.  The appropriately 
protected Fmoc-Glu(OCml)-OH is available commercially.  
Use of the corresponding aspartic acid residue is discouraged, 
however, because we observe formation of the cyclic 
aspartimide and the piperidide peptide by mass spectrometry.11  
We chose Rink amide resin for its stability to weak acid 
conditions and its generally robust quality.  This resin results 
in a primary amide at the C-terminus (peptide-NH2) upon 
cleavage with trifluoroacetic acid (TFA). 
To demonstrate this method we prepared two conjugates of 
sequence Ac-Trp-Glu(V)-NH2 (1-V) and Ac-Lys-Val-Asp-
Glu(V)-Ala-Tyr-Arg-NH2 (2-V), where Glu(V) is the 
viologen-conjugated Glu residue (Figure 1).  Conjugate 1-V 
was designed to provide an additional and orthogonal optical 
handle, via the indole of Trp, for quantitation by UV 
absorbance and to show whether any resin cleavage was 
occurring.  Conjugate 2-V was designed to demonstrate the 
compatibility of this method with various types of functional 
groups found in peptides, including alkyl, ammonium, 
carboxylic acid, phenol, and guanidinyl.  Accordingly, the 
sequences Ac-Trp-Glu(OCml)-Resin (1R-OCml) and Ac-Lys-
Val-Asp-Glu(OCml)-Ala-Tyr-Arg-Resin (2R-OCml) were 
prepared by standard, machine-assisted Fmoc protocols. 
Deprotection.  The cumyl ester protecting groups of the 
Glu(Cml) residues were removed using a 1% (v/v) mixture of 
trifluoroacetic acid in dichloromethane.  The aromatic product 
of this deprotection is liberated from the resin and can be 
followed quantitatively by UV spectroscopy, with max at 242 
nm in dichloromethane (Figure 1).  For peptides 1R-OCml 
and 2R-OCml we found that the absorbance at 242 nm 
increased over time and reached a maximum level at 45 
minutes, at which time the deprotection (to 1R-OH and 2R-
OH) was complete.  A red color is observed at higher 
concentrations of acid (e.g., 2 %), presumably corresponding 
to removal of Boc protecting groups on Trp or Lys.  We have 
found that longer peptides require longer reaction times for 
complete deprotection.  For example, a 30-mer peptide 
requires a deprotection time of 2 hours (data not shown).  This 
reaction does not appear to be sensitive to air or water. 
Activation.  The choice of activating group is important.  
We tried typical groups such as N-hydroxysuccinimide (NHS) 
and hydroxybenzotriazole  (HOBt), but we observed (i) low 
coupling yields, (ii) appearance of a blue color that indicates 
viologen reduction, and (iii) evidence for viologen decomposi- 
 
FIGURE 1. UV spectra of (top left) the supernatant of the 
deprotection reaction monitored in 15 minute intervals, showing 
increasing product until ~60 min; (top right) an overlay of equimolar 
PFP and DIC in DCM solution, showing the dominance of PFP above 
250 nm; (bottom right) the supernatant of the activation reaction 
before (blue) and after 15 min (red), showing a 20% decrease in PFP 
absorbance; (bottom left) the supernatant of the coupling reaction 
before (blue) and after (red) addition of DIEA, showing a 20% 
decrease in viologen absorbance. 
 
-tion in the NMR spectrum.  We speculated that the viologen 
reacts with the amine faster than the activated carboxylic acid.  
Therefore, we sought a more reactive activating group and 
found success with pentafluorophenol. 
The carboxylic acid sidechains of 1R-OH and 2R-OH were 
activated as pentafluorophenyl esters (1R-PFP and 2R-PFP) 
by reaction with diisopropylcarbodiimide (DIC) and 
pentafluorophenol (PFP), both at five molar equivalents with 
respect to Glu residues.  This well-known reaction is selective 
and efficient, but the resulting pentafluorophenyl ester is 
highly reactive with water.  Therefore, reagents and solvents 
must be anhydrous (and amine-free for DMF) and transferred 
by syringe or cannula.  In a mixture of PFP and DIC, the PFP 
is the dominant chromophore at 260 nm, and thus its 
disappearance from solution upon activation was followed by 
UV spectroscopy (Figure 1).  We observed a 20% decrease in 
absorbance within 15 minutes.  This decrease corresponds to 
removal of 1 out of the total 5 equivalents of PFP and thus 
indicates completion of the reaction.  We occasionally observe 
no change in absorbance, likely due to hydrolysis by 
contaminating water.  In these cases the resin is simply rinsed 
with dry solvent, and the reaction is performed again with 
fresh, dry reagents.   In contrast to the deprotection step, we 
find that activation time does not increase upon increasing the 
peptide chain up to 30 residues in length. 
Coupling.  In this step, the addition of a hindered base, 
diisopropylethylamine (DIEA) is used to carefully control the 
amount of free amine available for coupling to the resin.  
Addition of a large excess of DIEA results in the slow 
formation of a violet color, indicating reduction of the 
viologen.  In order to assure the controlled addition of DIEA, 
the resin is first rinsed with a solution of 1% (v/v) DIEA in 
DMF in order to remove traces of acid from the resin, and then 
with DMF in order to remove traces of DIEA. 
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The aminoethyl viologen was synthesized as its 
hydrobromide salt, 3, according to published methods.12,13  
The activated peptides 1R-PFP and 2R-PFP were treated with 
five equivalents of 3,14 and the resulting mixture was then 
titrated in three equal portions with a total of 2.4 equivalents 
of DIEA.15 This process is monitored by UV spectroscopy and 
shows an expected 20% decrease in absorbance at 264 nm 
immediately after the addition of the last aliquot of DIEA.  
This decrease corresponds to the removal of one equivalent of 
viologen from solution upon coupling to the resin (Figure 5).  
Care must be taken to keep water from contaminating this 
reaction.  If the reaction shows to be incomplete by UV 
spectroscopy, then the resin can be rinsed with dry solvent, 
and the activation and coupling steps repeated.  Longer 
reaction times were not required for peptides up to 30 residues 
in length. 
Conjugates 1-V and 2-V were cleaved from the resin with a 
mixture of (v/v/v) 95% TFA, 2.5% water, 2.5% 
triisopropylsilane, followed by concentration under high 
vacuum, resuspension in water, purification by reversed-phase 
HPLC, and lyophilization.  The viologen group significantly 
reduces the retention time on standard C4 and C18 silica 
columns, and it provides a UV absorbance at ~260 nm.  These 
properties facilitate the separation of conjugates from 
unreacted peptides.  In the case of separating peptide-viologen 
conjugates with different numbers of viologen groups,9 we 
suggest using an auxiliary chromophore, such as a tryptophan 
or tyrosine residue, as an internal UV standard. 
This paper describes a robust method for conjugating 
viologen groups to peptides using heterogeneous chemistry 
that is compatible with standard Fmoc-based solid-phase 
peptide synthesis. The use of UV-spectroscopy for 
quantitative monitoring of each reaction has allowed us to 
optimize reaction times as a function of peptide sequence and 
to assure completion of the water-sensitive activation and 
coupling steps.  In particular, time required for cumyl ester 
deprotection can vary significantly with peptide sequence, and 
in situ monitoring assures completion. The synthesis of 
conjugates 1-V and 2-V using these methods serves to 
illustrate the compatibility of this approach with a wide range 
of protein functional groups.  Such broad compatibility is 
much more difficult to achieve using solution-based 
approaches to asymmetric viologens.  Given the broad range 
of applications available to viologens, the methods reported 
here should improve upon existing synthetic routes and, more 
importantly, enable the synthesis of peptide-viologen 
conjugates for a wider range of applications.  Moreover, 
viologen-peptide conjugates themselves offer opportunities to 
study electron transfer in peptides and proteins16 with the 
advantages of site-specific labeling of the electroactive species 
and the elimination of a diffusion step in electron transfer to 
an unbound species. 
 
Experimental Section 
 
Materials.  All commercial reagents and solvents (HPLC 
grade or higher) were used without further purification: 
deuterium oxide (D2O), Fmoc-Glu(O-Cml)-OH (available 
commercially as "Fmoc-Glu(O-2-PhiPr)-OH"), Fmoc-Gly-
OH, Fmoc-Trp(Boc)-OH, Fmoc-Lys(Boc)-OH, Fmoc-Val-
OH, Fmoc-Asp(OtBu)-OH, Fmoc-Ala-OH, Fmoc-Tyr(tBu)-
OH, Fmoc-Arg(Pbf)-OH, Rink-Amide-MBHA Resin, HBTU, 
diisopropylcarbodiimide (DIC), pentafluorophenol (PFP), 
Biotech-grade N,N-dimethylformamide, diisoproplyethyl-
amine (DIEA), biotech-grade dimethylformamide (DMF), 
piperidine, dichloromethane (DCM), acetonitrile, acetic 
anhydride, anhydrous DMSO, triisopropyl silane (TIS). 
Viologen 3 was synthesized according to the published 
methods.12,13 
Instrumentation.  UV spectra were acquired at room temp.  
Preparatory HPLC was carried out with a Delta-pak C18, 
25x100 mm column.  A Delta-pak C18, 3.9x150mm column 
was used for analytical HPLC.  NMR spectra were collected in 
D2O at 25 C on a 400 MHz spectrometer.  Mass spectra were 
acquired with quadrupole detection and an electrospray ion 
source in positive ion mode.  Charges were assigned based on 
the separation between isotopic peaks. 
Peptide Synthesis.  Peptides were synthesized on 1.175  
10-4 mol scale on Rink amide MBHA resin (0.5 mmol/g 
loading) using an automated peptide synthesizer.  Cycles of 
deprotection and coupling proceeded with 20 min deprotection 
times in 20% (v/v) piperidine in DMF, and with 60 min 
coupling times in a preactivated solution of 4.70  10-4 mol 
HBTU, 4.70  10-4 mol Fmoc-amino acid, and 2.35  10-4 mol 
DIEA in 10 mL DMF.  When the sequence was completed, the 
N-terminal Fmoc group was removed, and the N-terminal 
amine was acetylated with a mixture of 2 mL acetic anhydride, 
2 mL DIEA, and 6 mL DMF for 30 min at room temperature.  
The resin was rinsed with DMF, DCM, methanol, and diethyl 
ether, and then dried under vacuum to a finely divided 
powder. 
Viologen Coupling.  The dry resin containing acetylated 
peptide (50 mol) was swelled in 10 mL DCM for 5 min, 
filtered, and then treated with 10 mL of 1 % (v/v) TFA in 
DCM for 60 min. To monitor the deprotection, 40 L is 
removed, diluted to 1 mL with DCM, and analyzed by UV 
spectroscopy (Figure 1, top left); the reaction is finished when 
the absorbance at 242 nm stops increasing.  Deprotection 
times longer than 60 min may be required for sequences 
longer than 10 residues.  The deprotected resin was then 
filtered, rinsed with dry DCM (3 x 10 mL), and treated with 
10 mL of a solution of 25 mM PFP and 25 mM DIC (i.e., 5 
equiv of each) in DCM for 15 minutes.  To monitor the 
activation, 40 L is removed, diluted to 1 mL with DCM, and 
analyzed by UV spectroscopy (Figure 1, bottom right); the 
reaction is complete if the absorbance at 260 nm has decreased 
to 80% of its starting value. The activated resin was then 
rinsed with DCM (2 x 10 mL) followed by a solution of 1% 
(v/v) DIEA in anhydrous DMF, and finally anhydrous DMF (2 
x 10 mL).  Separately, 250 mol of viologen 3 was stirred in 
10 mL anhydrous DMSO at 60 C for 15 min, at which time 
10 mL anhydrous DMF was added.  Overheating this sample 
causes decomposition that can be observed in the UV-visible 
spectrum.  The viologen solution was added to the resin and 
stirred.  Three aliquots of a 120 mM solution of DIEA in 
anhydrous DMF were added in 15 min intervals (300 L, 300 
L, 400 L) for a total of 2.4 equivalents DIEA added.  Two 
minutes after the last addition, the resin was rinsed with DMF 
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(2 x 10 mL) and DCM (2 x 10 mL).  To monitor the coupling 
reaction, 25 L was removed, diluted to 5 mL with anhydrous 
DMSO, and analyzed by UV spectroscopy (Figure 1, bottom 
left); the reaction is complete if the absorbance at 264 nm has 
decreased to 80% of its starting value.  When the reaction is 
complete, the resin is rinsed with DMF (3 x 10 mL) and DCM 
(3 x 10 mL).  Cleavage of the conjugate from the resin was 
accomplished by treating the resin with a solution of 95% 
TFA, 2.5% TIS, and 2.5% H2O (10 mL for 10 min, then 10 
mL for 60 min).  The resin was removed by filtration, and the 
solvent was removed under high vacuum.  The orange solid 
residue was dissolved in 0.1% (v/v) aqueous TFA (30 mL) and 
then purified by preparatory HPLC with an elution gradient of 
2%/min acetonitrile in 0.1% aqueous TFA.  Pure fractions 
were lyophilized to dryness to afford the conjugate as a light 
orange solid.   
1-V: (32 mg, 43% recovery of pure material).  1H NMR 
(400 MHz, D2O)  = 9.07 (d, 2H, J=6.8 Hz), 8.87 (d, 2H, 
J=6.8 Hz), 8.45 (d, 2H, J=7.2 Hz), 8.34 (d, 2H, J=7.2 Hz), 
7.50 (d, 1H, J=8.0 Hz), 7.41 (d, 1H, J=7.6 Hz), 7.21 (m, 4H), 
7.12 (t, 1H, J=7.6 Hz), approx 4.78 (m, 2H, occluded), 4.48 (t, 
1H, J=7.2 Hz), 4.42 (s, 3H), 3.99 (dd, 1H, J=4.8 Hz, 10.0 Hz), 
3.85 (m, 2H), 3.14 (m, 2H), 2.10 (t, 2H, J=7.2 Hz), 2.01 (s, 
3H), 1.88 (m, 1H), 1.64 (m, 1H).  13C NMR (100 MHz, D2O)  
= 178.4, 177.8, 177.1, 176.6, 165.8, 165.4, 152.9, 151.6, 
148.6, 148.5, 138.6, 129.3, 128.9, 127.1, 124.8, 122.2, 121.0, 
120.5, 117.6, 114.6, 111.4, 64.3, 58.1, 55.2, 51.0, 42.4, 33.7, 
29.4, 29.3, 24.4. ESI-MS m/z: calc. 285.6, found 285.8 [M]2+. 
2-V: (82 mg, 76% recovery of pure material).  1H NMR 
(D2O)  = 8.96 (d, 2H, J=6.96 Hz), 8.86 (d, 2H, J=6.96 Hz), 
8.36 (d, 2H, J=6.95 Hz), 8.31 (d, 2H, J=6.95), 6.89 (d, 2H, 
J=8.42 Hz), 6.57 (d, 2H, J=8.42), approximately 4.69-
occluded (m, 2H), 4.54 (t, 1H, J=7.32 Hz), 4.45 (dd, 1H, 
J=5.86, 6.22 Hz), 4.32 (s, 3H), 4.09 (m, 4H), 4.00 (m, 4H), 
3.72 (m, 2H), 2.95 (t, 2H, J=6.96 Hz), 2.91 (m, 1H), 2.84 (t, 
2H, J=7.69 Hz), 2.76 (m, 1H), 2.65 (m, 1H), 2.17 (t, 2H, 
J=7.69 Hz), 1.94 (m, 1H), 1.85 (s, 3H), 1.67 (m, 2H), 1.53 (p, 
2H, J=7.32 Hz), 1.43 (m, 1H), 1.27(m, 2H), 1.19 (d, 3H, 
J=6.96 Hz), 0.75 (d, 6H, J=6.90 Hz). 13C NMR  = 176.5, 
175.6, 174.8, 174.6, 174.2, 173.8, 173.4, 172.9, 172.3, 154.6, 
150.6, 149.5, 146.4, 146.0, 130.6, 128.1, 127.0, 126.7, 115.4, 
61.7, 59.7, 54.4, 54.1, 53.5, 53.1, 50.2, 50.0, 48.5, 40.6, 40.0, 
39.3, 35.9, 35.5, 31.3, 30.4, 30.2, 27.9, 26.6, 26.3, 24.2, 22.2, 
21.8, 18.5, 17.7, 16.6.  ESI-MS m/z: calc. 558.8, found 559.1 
[M]2+. 
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